Tarsus (TARS) Fundamental Analysis: Revenue, Earnings & Valuation

1.46 / 10

Underperform

Fundamentally, TARS is rated Underperform with a 1.5/10 strength. Cost of sales ratio and current liabilities ratio are relatively positive, but YoY revenue growth and PB‑ROE are poor. Overall, fundamentals are challenging, suggesting a guarded stance.

Analysis Checks(6/10)

Revenue-MV

Value-0.98

Score1/3

Weight62.99%

1M Return4.09%

Total operating revenue (YoY growth rate %)

Value146.71

Score0/3

Weight-54.57%

1M Return-4.79%

Inventory turnover ratio

Value8.78

Score2/3

Weight-14.46%

1M Return-1.18%

Current liabilities / Total liabilities (%)

Value62.04

Score2/3

Weight4.90%

1M Return0.36%

PB-ROE

Value5.00

Score0/3

Weight42.73%

1M Return2.74%

Long-term debt to working capital ratio (%)

Value0.21

Score3/3

Weight11.09%

1M Return0.87%

Interest coverage ratio (EBIT / Interest expense) (%)

Value35.11

Score2/3

Weight-14.70%

1M Return-1.17%

Operating revenue (YoY growth rate %)

Value146.71

Score2/3

Weight0.71%

1M Return0.05%

Cost of sales ratio (%)

Value6.80

Score3/3

Weight3.67%

1M Return0.26%

Asset-MV

Value-0.55

Score0/3

Weight57.64%

1M Return4.00%

Is TARS undervalued or overvalued?

TARS scores 1.46/10 on fundamentals and holds a Premium valuation at present. Backed by its -23.39% ROE, -14.72% net margin, -44.99 P/E ratio, 8.70 P/B ratio, and 48.21% earnings growth, these metrics solidify its Underperform investment rating.